Literature DB >> 15005243

Establishment and characterization of a human ovarian granulosa tumor cell line (HSOGT).

Haruhiro Kondo1, Kazushige Kiguchi, Asami Okamura, Yoshiaki Okuma, Tomohiro Iida, Yoichi Kobayashi, Masayuki Takagi, Bunpei Ishizuka, Isamu Ishiwata.   

Abstract

We successfully established a novel ovarian granulosa tumor cell line (HSOGT). The tumor tissue of the ovary was derived from a 25 year-old Japanese woman under her consent. The cell line was maintained for over 14 months, subcultured more than 73 times, and had a population doubling time of 18.9 hours. Phase contrast microscopy displayed a pavement-like arrangement without contact inhibition. The chromosome number showed a wide distribution of aneuploidy and the mode was 83; many marker chromosomes were observed. The HSOGT was also successfully xenotransplanted into nude mice. The cell line produced estradiol and has preserved some characters of granulosa cells with stable growth in vitro. We firmly believe that this cell line will be a most useful tool for endocrinological investigation of human granulosa cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15005243     DOI: 10.1111/j.1749-0774.2003.tb00144.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  25 in total

1.  Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer.

Authors:  M Koike; S Takeuchi; J Yokota; S Park; Y Hatta; C W Miller; N Tsuruoka; H P Koeffler
Journal:  Genes Chromosomes Cancer       Date:  1997-05       Impact factor: 5.006

Review 2.  Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium.

Authors:  Corrine Welt; Yisrael Sidis; Henry Keutmann; Alan Schneyer
Journal:  Exp Biol Med (Maywood)       Date:  2002-10

3.  Granulosa-theca cell tumors. A clinical review of 102 patients.

Authors:  A J Dinnerstein; J A O'Leary
Journal:  Obstet Gynecol       Date:  1968-05       Impact factor: 7.661

4.  A granulosa cell tumor in tissue culture.

Authors:  W R Goldston; G D Wilbanks; J A Campbell
Journal:  Am J Obstet Gynecol       Date:  1972-11-01       Impact factor: 8.661

5.  Production of steroids in one case of granulosa cell tumor in culture.

Authors:  M Shoji; K Ohkawa; H Hosoda; S Hachiya
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1980-10

6.  Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

Authors:  Y Nishi; T Yanase; Y Mu; K Oba; I Ichino; M Saito; M Nomura; C Mukasa; T Okabe; K Goto; R Takayanagi; Y Kashimura; M Haji; H Nawata
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

7.  Establishment and characterization of an estrogen-producing human ovarian granulosa tumor cell line.

Authors:  I Ishiwata; C Ishiwata; M Soma; N Kobayashi; H Ishikawa
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

8.  Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen.

Authors:  B L Lie; E Leung; P C Leung; N Auersperg
Journal:  Mol Cell Endocrinol       Date:  1996-07-01       Impact factor: 4.102

9.  Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.

Authors:  C K Welt; G Lambert-Messerlian; W Zheng; W F Crowley; A L Schneyer
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

10.  Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.

Authors:  J C Zenklusen; J N Weitzel; H G Ball; C J Conti
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

View more
  1 in total

1.  Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line.

Authors:  Misa Imai; Miho Muraki; Kiyoshi Takamatsu; Hidekazu Saito; Motoharu Seiki; Yuji Takahashi
Journal:  BMC Cancer       Date:  2008-11-04       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.